
Park Medi World shares rose to Rs 292 on the NSE on Monday, moving close to their record high of Rs 305. The stock has gained in three of the week’s four…
Park Medi World shares rose to Rs 292 on the NSE on Monday, moving close to their record high of Rs 305. The stock has gained in three of the week’s four sessions after the company reported its first-quarter FY27 results on 3 August. Emkay and Choice Broking turned bullish after the results, citing revenue and EBITDA growth of 19% and 20% year on year, improved profitability and hospital expansion plans.
Choice Broking set a long-term target of Rs 350, while Emkay raised its target to Rs 375 from Rs 350. The brokerages cited plans to increase capacity from 3,960 beds to more than 10,000 by FY33. Emkay expects around 1,800 additional beds over the next 18 months, while Choice expects 1,000 beds in FY28.
The easy story is that strong results and expansion guarantees a fresh peak. That overlooks execution risk, the burden of new hospitals and the stock’s dependence on brokerage estimates. The opposite claim, that government patients or Tier-2 cities make growth unattractive, is just as simplistic. Investors should watch occupancy, margins and the pace of bed additions, not targets alone. The next quarterly update should show whether the planned 1,000 FY28 beds are on schedule.
Source: livemint.com
This story was synthesised by AI from the source linked above.